Andreas Segerros

Vorsitzender bei DEXTECH MEDICAL AB

65 Jahre

Health Technology

Consumer Services

Finance

Profil

Andreas Rutger Segerros is currently Chief Executive Officer at Sylentis SAU since 2024.
Holds Chairman positions at Oncorena AB, Dextech Medical AB, and Oncorena Holding AB. Serves as Director at Prexton Therapeutics SA. Managing Partner at Eir Ventures Danmark ApS since 2020.
Formerly Chief Executive Officer at Nicox SA from 2022 to 2024.
Served as Chief Executive Officer at Clinitrac AB. Held Chairman role at CMC Contrast AB. Worked as Independent Director at Zyla Life Sciences LLC.
Director at Egalet Ltd. in 2011.
Director at RSPR Pharma AB. Head of Business Development & Operations Planning at Ferring Pharmaceuticals A. Principal at Pharmacia, Inc. Venture Partner at Sunstone Capital A from 2012 to 2019.
Education includes an MBA from the University of Uppsala and graduate studies at the Royal Institute of Technology.

Aktive Positionen von Andreas Segerros

Unternehmen	Position	Beginn
DEXTECH MEDICAL AB	Vorsitzender	-
Oncorena Holding AB Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Develops novel pharmacological treatment for metastasing clear cell renal cancer	Vorsitzender	-
Oncorena AB Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer	Vorsitzender	-
Eir Ventures Danmark ApS Eir Ventures Danmark ApS Investment ManagersFinance Functions as an alternative investment manager	Private Equity Investor	01.07.2020
Prexton Therapeutics SA Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Provides novel therapeutic compounds for treatment of Parkinson disease and other brain disorders	Direktor/Vorstandsmitglied	-
Sylentis SA Sylentis SA BiotechnologyHealth Technology Operates as a biotechnology company that focuses on the development of new ophthalmic drugs and novel therapies based on RNAi technology	Vorstandsvorsitzender	29.05.2024

Alle aktiven Positionen von Andreas Segerros

Ehemalige bekannte Positionen von Andreas Segerros

Unternehmen	Position	Ende
NICOX SA	Vorstandsvorsitzender	28.02.2024
Sunstone Capital A/S Sunstone Capital A/S Investment ManagersFinance Sunstone is an active manager which provides equity funding for early-stage capital requirements, and provides management support. The firm targets companies operating in the technology and life sciences sector, and industries such as biotechnology, pharmaceuticals, and information technology services. Sunstone invests in companies located in Denmark and Northern Europe, and looks to take minority stake positions in its investments, as well as a seat on the board.	Private Equity Investor	01.02.2019
Ferring Pharmaceuticals A/S Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Specializes in the development, production and marketing of pharmaceutical products	Corporate Officer/Principal	-
░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░░ ░░░░ ░░░░░░░░	░░░░░░░░░░░░░░░░░░░░░░░░░░	-

Sehen Sie sich die Erfahrung von Andreas Segerros im Detail an

Ausbildung von Andreas Segerros

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Andreas Segerros im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	17
CMC Contrast AB CMC Contrast AB Pharmaceuticals: MajorHealth Technology develops magnetic resonance contrast agents for patients suffering with tumors	Health Technology
Zyla Life Sciences LLC Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for patients with acute and chronic pain	Health Technology
Nicox SA Nicox SA Pharmaceuticals: MajorHealth Technology Manufactures and sells ophthalmology biopharmaceuticals	Health Technology
Ferring Pharmaceuticals A/S Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Specializes in the development, production and marketing of pharmaceutical products	Health Technology
Clinitrac AB Clinitrac AB Packaged SoftwareTechnology Services Develops wireless patient diaries	Technology Services
University of Uppsala University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Egalet Ltd. Egalet Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Health Technology
Royal Institute of Technology Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pharmacia, Inc.
Sunstone Capital A/S Sunstone Capital A/S Investment ManagersFinance Sunstone is an active manager which provides equity funding for early-stage capital requirements, and provides management support. The firm targets companies operating in the technology and life sciences sector, and industries such as biotechnology, pharmaceuticals, and information technology services. Sunstone invests in companies located in Denmark and Northern Europe, and looks to take minority stake positions in its investments, as well as a seat on the board.	Finance
RSPR Pharma AB RSPR Pharma AB Pharmaceuticals: MajorHealth Technology Develops therapeutics for inflammatory vascular diseases	Health Technology
Sylentis SA Sylentis SA BiotechnologyHealth Technology Operates as a biotechnology company that focuses on the development of new ophthalmic drugs and novel therapies based on RNAi technology	Health Technology
Oncorena AB Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer	Health Technology
Prexton Therapeutics SA Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Provides novel therapeutic compounds for treatment of Parkinson disease and other brain disorders	Health Technology
Dextech Medical AB Dextech Medical AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of drug candidates for urologic oncology	Health Technology
Oncorena Holding AB Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Develops novel pharmacological treatment for metastasing clear cell renal cancer	Health Technology
Eir Ventures Danmark ApS Eir Ventures Danmark ApS Investment ManagersFinance Functions as an alternative investment manager	Finance